The trademark Clarity was filed by Clarity Health Technologies, a U.S. corporation (the "Applicant"). The application was published for oppositions on September 15, 2021, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on December 14, 2021 by Saluda Medical Pty Ltd on Likelihood of confusion. the opponent was represented by rwzh Rechtsanwälte Wachinger Zoebisch Partnerschaft mbB and its proceedings were handled in English The second opposition filed on November 4, 2021 by PAUL HARTMANN AG on Likelihood of confusion. the opponent was represented by STUMPF PATENTANWÄLTE PARTGMBB and its proceedings were handled in English
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).
A transfer of the trademark registration was recorded on January 12, 2023.
The application claimed as seniority of the French Republic trademark 4691312 and filed on October 12, 2020 which was accepted by the office.
Goods And Services
The mark was filed in class 9 with following description of goods:
Computer software relating to the medical field
Virtual reality software
Science software enabling telemedicine services, digital diagnoses and remote health monitoring
Wearable brain activity sensors
All the aforementioned goods related to digital therapeutics for Alzheimer's disease and associated dementia and excluding neuromodulation therapy for the management of chronic, intractable pain and via closed loop stimulation.
The mark was filed in class 10 with following description of goods:
Electrodes for picking up electrophysiological parameters
Neuromodulation devices for therapeutic treatments, Brain pacemakers
Testing apparatus for medical purposes
Apparatus for the diagnosis of neurological diseases
Tools for medical diagnostics
Implanted neuroprostheses
All the aforementioned goods related to digital therapeutics for Alzheimer's disease and associated dementia and excluding neuromodulation therapy for the management of chronic, intractable pain and via closed loop stimulation.